Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma

Published:2021-03 Issue:1 Volume:67 Page:
ISSN:2724-5985
Container-title:Minerva Gastroenterology
language:
Short-container-title:Minerva Gastroenterol

Author:

FERRARESE Alberto,SCIARRONE Salvatore S.,PELLONE Monica,SHALABY Sarah,BATTISTELLA Sara,ZANETTO Alberto,GERMANI Giacomo,RUSSO Francesco P.,SENZOLO Marco,BURRA Patrizia,GAMBATO Martina

Publisher

Edizioni Minerva Medica

Subject

Gastroenterology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R08Y2021N01A0004

Reference45 articles.

1. Molecular therapies and precision medicine for hepatocellular carcinoma

2. Sorafenib in Advanced Hepatocellular Carcinoma

3. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

4. Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study

5. Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma;Minerva Gastroenterology;2022-12

2. Observation on the effect and effective rate of contrast-enhanced ultrasonography in interventional therapy for primary hepatocellular carcinoma;Minerva Gastroenterology;2022-09

3. Circular RNA Circ_0008043 promotes the proliferation and metastasis of hepatocellular carcinoma cells by regulating the microRNA (miR)-326/RAB21 axis;Bioengineered;2022-02-27

4. The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma;Medicina;2022-02-01

5. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?;International Journal of Molecular Sciences;2022-01-02